|
|
|
Insider
Information: |
Novo A/s |
Relationship: |
10% Owner |
City: |
Bagsvaerd |
State: |
G7 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
43 |
|
Direct
Shares |
93,548,310 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$749,128,598 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
93,548,310 |
|
|
Total
Value |
$749,128,598 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
26
|
Stock
price went up :
|
0
|
14
|
Stock
price went down : |
5
|
12
|
|
|
|
Gain/Loss Ratio : |
-5.0
|
1.2
|
Percentage
Gain/Loss : |
-52.1%
|
-223.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomimetic Therapeutics, Inc. |
BMTI |
10% Owner |
2013-03-01 |
0 |
2006-05-11 |
0 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2016-12-15 |
0 |
2013-09-30 |
0 |
Premium* |
|
Inogen Inc |
INGN |
10% Owner |
2021-06-02 |
2,079,320 |
|
0 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
10% Owner |
2015-06-22 |
2,133,131 |
2014-02-18 |
0 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
SEE REMARKS, 10% Owner |
2014-03-25 |
1,516,387 |
2014-03-25 |
0 |
Premium* |
|
Alder Biopharmaceuticals Inc |
ALDR |
SEE REMARKS, 10% Owner |
2014-05-13 |
3,201,183 |
2014-05-13 |
0 |
Premium* |
|
Zs Pharma, Inc. |
ZSPH |
See Remarks, 10% Owner |
2014-06-23 |
781,730 |
2014-06-23 |
0 |
Premium* |
|
Otonomy, Inc. |
OTIC |
SEE REMARKS, 10% Owner |
2014-08-19 |
2,175,025 |
2014-08-18 |
0 |
Premium* |
|
Nevro Corp |
NVRO |
SEE REMARKS, 10% Owner |
2014-11-12 |
2,194,841 |
2014-11-12 |
0 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-07-13 |
1,875,905 |
2015-05-04 |
0 |
Premium* |
|
Htg Molecular Diagnostics, Inc |
HTGM |
10% Owner |
2017-08-25 |
0 |
2015-05-11 |
0 |
Premium* |
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2016-09-09 |
3,156,563 |
2015-05-11 |
0 |
Premium* |
|
Corvus Pharmaceuticals, Inc. |
CRVS |
10% Owner |
2020-07-08 |
1,389,498 |
2016-03-29 |
0 |
Premium* |
|
Reata Pharmaceuticals Inc |
RETA |
10% Owner |
2017-06-14 |
592,794 |
2016-06-01 |
0 |
Premium* |
|
Irhythm Technologies, Inc. |
IRTC |
10% Owner |
2016-10-25 |
2,124,448 |
|
0 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
2,031,562 |
2016-10-31 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2017-10-12 |
0 |
|
0 |
Premium* |
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2017-07-26 |
1,301,842 |
|
0 |
Premium* |
|
Anaptysbio Inc |
ANAB |
10% Owner |
2017-08-21 |
1,936,604 |
2017-01-31 |
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
2,181,843 |
2018-09-28 |
0 |
Premium* |
|
Milestone Pharmaceuticals Inc. |
MIST |
10% Owner |
2019-05-13 |
2,674,470 |
2019-05-13 |
0 |
Premium* |
|
Morphic Holding, Inc. |
MORF |
10% Owner |
2019-06-28 |
2,645,446 |
2019-06-28 |
0 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
2,445,147 |
2019-07-22 |
0 |
Premium* |
|
Galera Therapeutics, Inc. |
GRTX |
10% Owner |
2021-02-18 |
2,459,021 |
2019-11-12 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
2,793,865 |
2020-07-14 |
0 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2021-01-28 |
2,194,379 |
2020-07-28 |
0 |
Premium* |
|
Checkmate Pharmaceuticals, Inc. |
CMPI |
10% Owner |
2022-02-25 |
2,161,990 |
2020-08-11 |
0 |
Premium* |
|
Harmony Biosciences Holdings, Inc. |
HRMY |
10% Owner |
2020-08-21 |
3,754,973 |
2020-08-21 |
0 |
Premium* |
|
Spruce Biosciences, Inc. |
SPRB |
10% Owner |
2024-03-21 |
2,550,000 |
2020-10-14 |
0 |
Premium* |
|
Praxis Precision Medicines, Inc. |
PRAX |
10% Owner |
2020-10-20 |
2,442,080 |
2020-10-20 |
0 |
Premium* |
|
Aligos Therapeutics, Inc. |
ALGS |
10% Owner |
2020-10-20 |
2,614,563 |
2020-10-20 |
0 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
887,071 |
2020-10-20 |
0 |
Premium* |
|
Galecto Inc. |
GLTO |
10% Owner |
2020-11-02 |
2,497,791 |
2020-11-02 |
0 |
Premium* |
|
Bolt Biotherapeutics, Inc. |
BOLT |
10% Owner |
2022-07-13 |
3,703,991 |
|
0 |
Premium* |
|
Edgewise Therapeutics, Inc. |
EWTX |
10% Owner |
2022-09-14 |
6,071,703 |
2021-03-30 |
0 |
Premium* |
|
Reneo Pharmaceuticals, Inc. |
RPHM |
10% Owner |
2023-06-23 |
3,330,337 |
2021-04-13 |
0 |
Premium* |
|
Cyteir Therapeutics, Inc. |
CYT |
10% Owner |
2023-07-20 |
3,522,136 |
2021-06-22 |
0 |
Premium* |
|
Verve Therapeutics, Inc. |
VERV |
10% Owner |
2021-06-21 |
793,265 |
2021-06-21 |
0 |
Premium* |
|
Minerva Surgical Inc |
UTRS |
10% Owner |
2021-10-26 |
2,057,132 |
2021-10-26 |
0 |
Premium* |
|
Io Biotech, Inc. |
IOBT |
|
2024-05-10 |
4,429,449 |
2021-11-09 |
0 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-02-08 |
4,016,878 |
2022-02-08 |
0 |
Premium* |
|
Disc Medicine, Inc |
IRON |
10% Owner |
2023-06-28 |
1,090,772 |
|
0 |
Premium* |
|
Metagenomi, Inc. |
MGX |
10% Owner |
2024-02-13 |
1,739,175 |
2024-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
238 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-06-27 |
4 |
S |
$1.77 |
$56,687 |
D/D |
(31,978) |
3,863,573 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-06-30 |
4 |
S |
$2.63 |
$529,288 |
D/D |
(200,937) |
3,662,636 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-07-14 |
4 |
S |
$2.74 |
$30,102 |
D/D |
(11,000) |
3,651,636 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-07-17 |
4 |
S |
$2.75 |
$58,000 |
D/D |
(21,100) |
3,630,536 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-07-18 |
4 |
S |
$2.76 |
$17,923 |
D/D |
(6,500) |
3,624,036 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-07-19 |
4 |
S |
$2.76 |
$5,247 |
D/D |
(1,900) |
3,622,136 |
0 |
% |
|
CYT |
Cyteir Therapeutics, Inc. |
10% Owner |
|
2023-07-20 |
4 |
S |
$2.75 |
$275,140 |
D/D |
(100,000) |
3,522,136 |
0 |
% |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2020-10-20 |
4 |
B |
$18.00 |
$2,700,000 |
D/D |
150,000 |
887,071 |
2.45 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
737,071 |
737,071 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
10% Owner |
|
2018-09-28 |
4 |
B |
$15.00 |
$16,347,525 |
D/D |
1,089,835 |
2,181,843 |
2.45 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
10% Owner |
|
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,092,008 |
1,092,008 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
10% Owner |
|
2021-03-30 |
4 |
B |
$16.00 |
$10,000,000 |
D/D |
625,000 |
5,587,207 |
2.45 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
10% Owner |
|
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,962,207 |
4,962,207 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
10% Owner |
|
2022-09-14 |
4 |
B |
$10.32 |
$4,999,999 |
D/D |
484,496 |
6,071,703 |
2.45 |
- |
|
FLXN |
Flexion Therapeutics Inc |
SEE REMARKS |
|
2014-02-18 |
4 |
B |
$13.00 |
$9,000,004 |
D/D |
692,308 |
1,783,131 |
2.45 |
- |
|
FLXN |
Flexion Therapeutics Inc |
SEE REMARKS |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,090,823 |
1,090,823 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
10% Owner |
|
2014-12-17 |
4 |
B |
$17.00 |
$8,500,000 |
D/D |
500,000 |
2,283,131 |
2.45 |
- |
|
FLXN |
Flexion Therapeutics Inc |
10% Owner |
|
2015-06-18 |
4 |
S |
$21.51 |
$767,903 |
D/D |
(35,700) |
2,247,431 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
10% Owner |
|
2015-06-19 |
4 |
S |
$20.07 |
$1,021,225 |
D/D |
(50,888) |
2,196,543 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
10% Owner |
|
2015-06-22 |
4 |
S |
$20.55 |
$1,302,844 |
D/D |
(63,412) |
2,133,131 |
0 |
- |
|
GLTO |
Galecto Inc. |
10% Owner |
|
2020-11-02 |
4 |
B |
$15.00 |
$4,999,995 |
D/D |
333,333 |
2,497,791 |
2.45 |
- |
|
GLTO |
Galecto Inc. |
10% Owner |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,164,458 |
2,164,458 |
0 |
- |
|
GRTX |
Galera Therapeutics, Inc. |
SEE REMARKS |
|
2019-11-12 |
4 |
B |
$12.00 |
$6,000,000 |
D/D |
500,000 |
3,409,021 |
2.45 |
- |
|
GRTX |
Galera Therapeutics, Inc. |
SEE REMARKS |
|
2019-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,909,021 |
2,909,021 |
0 |
- |
|
GRTX |
Galera Therapeutics, Inc. |
10% Owner |
|
2020-10-15 |
4 |
S |
$11.00 |
$4,950,000 |
D/D |
(450,000) |
2,959,021 |
0 |
% |
|
238 Records found
|
|
Page 5 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|